Myricetin and dihydromyricetin from edible plants as promising neuroprotective agents for neuropsychiatric disorders

Neuropsychiatric disorders contribute substantially to global disability and place a sustained burden on patients, families, and health systems. Safer plant-derived bioactive compounds are therefore needed, because many current pharmacotherapies offer limited efficacy and cause serious adverse effects. Berries, vine tea, and edible plants including Myrica species contain the naturally occurring flavonoids myricetin and its dihydroflavonol analog, dihydromyricetin. Owing to their diverse pharmacological properties, particularly their neuroprotective effects, myricetin and dihydromyricetin have attracted considerable attention. The neuroprotective benefits of myricetin and dihydromyricetin in models of Parkinson's disease, Alzheimer's disease, cerebral ischemia/reperfusion injury, depression, anxiety, and cognitive impairment of diverse origins were summarized in this review, based on recent preclinical research. The underlying mechanisms spanned antioxidant defense, ferroptosis inhibition, suppression of neuroinflammation, restoration of autophagy, and modulation of the gut–brain axis, neurotransmitter systems, and neurotrophic factors. We also reviewed the physicochemical and pharmacokinetic properties of both compounds, together with delivery strategies now under investigation, including nanocarriers, cyclodextrins, and phospholipid complexes, intended to improve oral bioavailability and brain targeting. On this basis, the review outlined a preclinical framework for developing myricetin and dihydromyricetin as functional ingredients or nutraceuticals. However, current evidence is predominantly preclinical, and clinical safety and efficacy remain to be established.

Authors

Institutions

Publication Details

Journal
Journal of Functional Foods
Published
2026-11-12
DOI
https://doi.org/10.1016/j.jff.2026.107584
Primary Topic
Medicinal plant effects and applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Myricetin and dihydromyricetin from edible plants as promising neuroprotective agents for neuropsychiatric disorders

欧阳柳凤, Nanjia Cairang, Cai Rangji, Wenjun Wang et al.
Journal of Functional Foods
Medicinal plant effects and applications
article

Myricetin and dihydromyricetin from edible plants as promising neuroprotective agents for neuropsychiatric disorders

欧阳柳凤, Nanjia Cairang, Cai Rangji, Wenjun Wang, Bochao Zhang, Liping Guo, Yanping Cheng, Mingli Liu, Jie Gao, Danzeng Miji, Wei Ge
article en

Abstract

Neuropsychiatric disorders contribute substantially to global disability and place a sustained burden on patients, families, and health systems. Safer plant-derived bioactive compounds are therefore needed, because many current pharmacotherapies offer limited efficacy and cause serious adverse effects. Berries, vine tea, and edible plants including Myrica species contain the naturally occurring flavonoids myricetin and its dihydroflavonol analog, dihydromyricetin. Owing to their diverse pharmacological properties, particularly their neuroprotective effects, myricetin and dihydromyricetin have attracted considerable attention. The neuroprotective benefits of myricetin and dihydromyricetin in models of Parkinson's disease, Alzheimer's disease, cerebral ischemia/reperfusion injury, depression, anxiety, and cognitive impairment of diverse origins were summarized in this review, based on recent preclinical research. The underlying mechanisms spanned antioxidant defense, ferroptosis inhibition, suppression of neuroinflammation, restoration of autophagy, and modulation of the gut–brain axis, neurotransmitter systems, and neurotrophic factors. We also reviewed the physicochemical and pharmacokinetic properties of both compounds, together with delivery strategies now under investigation, including nanocarriers, cyclodextrins, and phospholipid complexes, intended to improve oral bioavailability and brain targeting. On this basis, the review outlined a preclinical framework for developing myricetin and dihydromyricetin as functional ingredients or nutraceuticals. However, current evidence is predominantly preclinical, and clinical safety and efficacy remain to be established.

Journal of Functional FoodsVol. 147
Yan'an University (CN), Xijing Hospital (CN), Southwest Minzu University (CN), Air Force Medical University (CN)
National Natural Science Foundation of China, Natural Science Basic Research Program of Shaanxi Province
Good health and well-being, Zero hunger
Medicinal plant effects and applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon